Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by synthetic DNA from biologic drugs to biomanufacturing, and DNA-based data storage. Funding will advance next-generation technology platform, expand R&D and manufacturing facilities, grow multidisciplinary team, and launch DNA synthesis service. Ansa is solving current industry bottlenecks associated with synthesizing complex […]
Today, Finnish Organ-On-Chip startup Finnadvance announced that they’ve secured a €1.2 million seed financing round led by Finnish investor Athensmed. Several existing investors, such as deep tech VC Voima Ventures and early-stage VC Icebreaker, are participating in the funding round. In addition, the funding also includes a new investor: Takoa Invest. Finnadvance is a biotechnology start-up […]
Extension of previous funding round brings total raised to £7 million GBP (circa $9.2 million USD) Investment from Calculus Capital, Par Equity, and Scottish Enterprise Funding will support continued development of Axol’s human iPS cell lines and reagents, and expansion of its commercial team Cambridge, UK: Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, […]
Tolochenaz, Vaud, Switzerland — Nanolive SA, a leading live cell imaging and analysis company, announces today that it has successfully completed the initial closing of US $20 million in the Series C-1 equity financing round of investment, led by a US-based and NASDAQ listed life science investor, and Taiwania Capital, the leading life science venture capital […]
Recently, China’s leading company in animal cell culture technology and domestic serum-free culture media, Shanghai BioEngine Sci-Tech Co., LTD, announced the completion of a 200 million RMB Series B++ financing round. The financing was led by Legend Capital, followed by Addor Capital and Tsing Song Capital, and the old shareholder Hankang Capital continued to increase […]
Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a Director Candidate Recommended by Caligan, if Casdin and Viking Transaction Closes Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting SOUTH SAN […]
Ampersand investment opportunity Syft is pleased to announce that it has reached an agreement with Ampersand Capital Partners (Ampersand) to invest $22.8m in Syft, subject to shareholder approval. Ampersand will subscribe to 17,545,000 convertible preference shares, equivalent to 19.6% of the total shares post-investment, at a price of $1.30 per share. Ampersand is a Boston, […]
Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting Parties to Terminate the Purchase Agreements if Stockholder Approval is Not Received on April 1 SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into an agreement with Casdin Capital, LLC (“Casdin”) and Viking Global Investors LP […]
HILLERØD — Today, FOSS announced its annual result for 2021 and unveiled a record revenue for the company, a strong profit and increased investment in innovation. The digital investments of recent years have strengthened the business in a year of global crises and have created the foundation for more growth. In 2021, FOSS had a […]
Provides Stockholders Additional Time to Consider $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced that it convened and then adjourned, without conducting any other business, the Company’s Special Meeting of Stockholders (the “Special Meeting”) to provide stockholders additional time to vote on […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
